Cargando…
Correction to: clinical significance of high monocyte counts for the continuous treatment with nintedanib
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362552/ https://www.ncbi.nlm.nih.gov/pubmed/37479988 http://dx.doi.org/10.1186/s12890-023-02573-7 |
_version_ | 1785076447443943424 |
---|---|
author | Tsuneyoshi, Shingo Zaizen, Yoshiaki Tominaga, Masaki Matama, Goushi Umemoto, Shushi Ohno, Shuuhei Takaki, Reiko Yano, Ryo Murotani, Kenta Okamoto, Masaki Hoshino, Tomoaki |
author_facet | Tsuneyoshi, Shingo Zaizen, Yoshiaki Tominaga, Masaki Matama, Goushi Umemoto, Shushi Ohno, Shuuhei Takaki, Reiko Yano, Ryo Murotani, Kenta Okamoto, Masaki Hoshino, Tomoaki |
author_sort | Tsuneyoshi, Shingo |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10362552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-103625522023-07-23 Correction to: clinical significance of high monocyte counts for the continuous treatment with nintedanib Tsuneyoshi, Shingo Zaizen, Yoshiaki Tominaga, Masaki Matama, Goushi Umemoto, Shushi Ohno, Shuuhei Takaki, Reiko Yano, Ryo Murotani, Kenta Okamoto, Masaki Hoshino, Tomoaki BMC Pulm Med Correction BioMed Central 2023-07-21 /pmc/articles/PMC10362552/ /pubmed/37479988 http://dx.doi.org/10.1186/s12890-023-02573-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correction Tsuneyoshi, Shingo Zaizen, Yoshiaki Tominaga, Masaki Matama, Goushi Umemoto, Shushi Ohno, Shuuhei Takaki, Reiko Yano, Ryo Murotani, Kenta Okamoto, Masaki Hoshino, Tomoaki Correction to: clinical significance of high monocyte counts for the continuous treatment with nintedanib |
title | Correction to: clinical significance of high monocyte counts for the continuous treatment with nintedanib |
title_full | Correction to: clinical significance of high monocyte counts for the continuous treatment with nintedanib |
title_fullStr | Correction to: clinical significance of high monocyte counts for the continuous treatment with nintedanib |
title_full_unstemmed | Correction to: clinical significance of high monocyte counts for the continuous treatment with nintedanib |
title_short | Correction to: clinical significance of high monocyte counts for the continuous treatment with nintedanib |
title_sort | correction to: clinical significance of high monocyte counts for the continuous treatment with nintedanib |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362552/ https://www.ncbi.nlm.nih.gov/pubmed/37479988 http://dx.doi.org/10.1186/s12890-023-02573-7 |
work_keys_str_mv | AT tsuneyoshishingo correctiontoclinicalsignificanceofhighmonocytecountsforthecontinuoustreatmentwithnintedanib AT zaizenyoshiaki correctiontoclinicalsignificanceofhighmonocytecountsforthecontinuoustreatmentwithnintedanib AT tominagamasaki correctiontoclinicalsignificanceofhighmonocytecountsforthecontinuoustreatmentwithnintedanib AT matamagoushi correctiontoclinicalsignificanceofhighmonocytecountsforthecontinuoustreatmentwithnintedanib AT umemotoshushi correctiontoclinicalsignificanceofhighmonocytecountsforthecontinuoustreatmentwithnintedanib AT ohnoshuuhei correctiontoclinicalsignificanceofhighmonocytecountsforthecontinuoustreatmentwithnintedanib AT takakireiko correctiontoclinicalsignificanceofhighmonocytecountsforthecontinuoustreatmentwithnintedanib AT yanoryo correctiontoclinicalsignificanceofhighmonocytecountsforthecontinuoustreatmentwithnintedanib AT murotanikenta correctiontoclinicalsignificanceofhighmonocytecountsforthecontinuoustreatmentwithnintedanib AT okamotomasaki correctiontoclinicalsignificanceofhighmonocytecountsforthecontinuoustreatmentwithnintedanib AT hoshinotomoaki correctiontoclinicalsignificanceofhighmonocytecountsforthecontinuoustreatmentwithnintedanib |